Malik Shahzad 4
4 · Acutus Medical, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Malik Shahzad
Director
Transactions
- Award
Common Stock
2021-06-17+1,800→ 4,022 total - Award
Stock Options (Right to Buy)
2021-06-17+7,022→ 7,022 totalExercise: $16.66Exp: 2031-06-17→ Common Stock (7,022 underlying)
Holdings
- 1,551,713(indirect: See footnote)
Common Stock
- 65,436(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting person has remained in continuous service as a director
- [F2]These shares are held by Advent Life Sciences LLP ("Advent"). The Reporting Person is a general partner of Advent, and disclaims beneficial ownership of the securities held by Advent except to the extent of his indirect pecuniary interest therein.
- [F3]These shares are held by Advent Life Sciences Fund I LP. Advent is the general partner of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent. The Reporting Person disclaims beneficial ownership of the securities held by Advent Life Sciences Fund II LP except to the extent of his indirect pecuniary interest therein.
- [F4]Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director.